دورية أكاديمية

Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.

التفاصيل البيبلوغرافية
العنوان: Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.
المؤلفون: Nettis, Eustachio, Cegolon, Luca, Di Leo, Elisabetta, Lodi Rizzini, Fabio, Detoraki, Aikaterini, Canonica, Giorgio Walter, Nettis, E, Cegolon, L, Leo, E Di, Rizzini, F Lodi, Detoraki, A, Canonica, W G, Italian OCUReL study group
المصدر: Annals of Allergy, Asthma & Immunology; Oct2018, Vol. 121 Issue 4, p474-478, 5p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:10811206
DOI:10.1016/j.anai.2018.06.014